The S&P is flat on the year. The Nasdaq is red. Meanwhile, the most boring corner of the market just quietly posted a 11.68% gain and nobody's talking about it.

The Dow Jones U.S. Dividend 100 Index (the benchmark behind America's most popular dividend ETF) is crushing everything in 2026. Not by a little. By double digits over its own large-value category. And it just reshuffled its entire deck last week with 25 new stocks.

We break down what changed, what got kicked out, and why dividend investors might finally be having their "I told you so" moment below.

This is not financial advice. Always do your own research. Past performance doesn’t guarantee future results.

Today’s sponsor

When Forbes flags a mineral as "the most important mineral you've never heard of," it's worth paying attention.

This one strengthens ammunition.
Supports missile systems.
Protects aircraft and defense gear.

Yet most supply sits overseas with China and Russia.

That imbalance is critical for the West. The U.S. needs North American sources and the government is not being shy in their search.

A high-grade deposit just miles from the U.S. border is now being drilled and expanded.

The spotlight hasn't fully turned here yet. But it's starting to.

Discover the company positioned as this metal moves into focus >

While mega-cap tech wobbles and oil keeps the indexes on a leash, one group of investors has been quietly collecting checks and watching their portfolios climb: dividend stock holders.

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks the Dow Jones U.S. Dividend 100 Index, is up 11.68% year-to-date as of March 26. The large-value category it belongs to? Just 6.44%. That's a huge lead.

And the timing couldn't be better, because SCHD just completed its annual reconstitution last week, which is the once-a-year reshuffling where the index decides which dividend stocks make the cut and which get sent packing. 22 stocks were removed. 25 new ones were added. Three new names cracked the top 10: Amgen, Abbott Laboratories, and… UnitedHealth Group.

The sector shifts are telling. Energy's weighting dropped from roughly 20% down to 16.5%. Healthcare jumped to 18.6%. Tech climbed to 11%. The index is moving away from the cyclical energy trade that powered 2025 and leaning into steadier, more defensive cash-flow machines, the kind of companies that keep paying you whether markets go up, down, or sideways.

With the current yield sitting around 3.45% and capital appreciation running at nearly 16% on top of it, SCHD investors are getting paid to wait while the rest of the market figures out what it wants to be. For years, dividend investing was the punchline. 2026 flipped the script. Sometimes the boring trade wins.

Markets climbed on Wednesday on cautious optimism that diplomatic talks could ease the Middle East conflict.

Corporate earnings are defying the Iran chaos. Wall Street analysts keep boosting profit outlooks even as geopolitical tensions rock markets. S&P 500 earnings are now expected to jump 20% over the next 12 months, a growth rate historically seen only during post-recession recoveries. Morgan Stanley's Mike Wilson notes that profit revisions climbing while stock prices fall rarely happens during geopolitical crises, and historically signals strong performance ahead.

A Los Angeles jury nailed Meta and Google with $3 million in damages in a landmark trial over social media addiction, finding both companies designed their platforms to hook young users. Meta was ordered to pay 70% of the award, and Google the rest. The jury also found both acted with "malice, oppression, or fraud" meaning punitive damages are still coming. The verdict arrived after nine days of deliberations in the first case to test whether social media companies can be held liable for youth mental health harms.

Arm stock rocketed 15% after the company unveiled its first production data center processor, the AGI CPU, along with server racks to run them at scale. The chip targets the shift toward agentic AI applications, where CPUs matter more than GPUs. Meta is deploying them alongside its custom chips, and Arm claims the AGI delivers twice the performance per rack compared to Intel and AMD's x86 platforms. Still, BofA analyst Vivek Arya warned the CPU market is "very crowded" with established players and hyperscalers building their own custom chips.

James van Geelen is back, and this time he's betting bond traders are wrong. The Citrini Research founder who crashed markets last month with his AI-doom post now argues the Fed won't raise rates despite spiking oil prices. He's wagering that the oil shock will deal enough economic damage to keep cuts on the table, not hikes. His firm is buying three-month SOFR futures and shorting equities, both bets that benefit if the economy stumbles.

Our parent company Invested Inc. is launching a new podcast called Owners Only, all about how some of the biggest content creators out there are building their followings into fully functioning businesses.

The first guest? Zach Justice.

Your feedback matters to us! Let us know what you liked or didn’t like about today’s edition.

That’s all for today. Did we miss anything? Smash the reply button to let me know.

Cheers,
Brandon & Blake of Invested Inc